Edwards Lifesciences Corp
I · Análisis con IA
En breve
Edwards Lifesciences makes medical devices to treat advanced heart diseases, focusing on transcatheter heart valve replacement (SAPIEN family), valve repair products (PASCAL, EVOQUE), and surgical structural heart solutions (INSPIRIS line) [Company Overview]. They sell through direct sales teams and distributors across the United States, Europe, Japan, and other international markets [Company Overview].
Edwards Lifesciences is a $47,3B medical device company specializing in advanced heart valve replacement and repair products, serving patients with serious cardiovascular diseases [Yahoo Finance]. The company has lagged the S&P 500 significantly over the past year (+7,8% vs. +26,6%), suggesting investor caution despite strong underlying financials [Yahoo Finance]. Recent insider selling activity and a JPMorgan Chase position reduction warrant attention [SEC Form 4] [EODHD].
Edwards is financially robust with excellent margins, zero net debt, and strong cash generation [Yahoo Finance].
Puntuación Sentinellis
9,5/10
Financieramente sana
Capitalización bursátil
$47,3B
Ingresos (12 meses)
$6,1B
Explicaciones
Cómo leemos estas cifras
Guías en lenguaje sencillo · sin cuenta
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LeerPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LeerAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LeerII · Noticias recientes
Qué movió el precio
1 noticia · ordenadas por relevancia
- Macro2026-05-14
Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?
Yahoo Finance
Premium · gratis con cualquier cuenta
The stock trades at a premium 44,4x P/E ratio, which magnifies downside risk if growth disappoints or margins compress [Yahoo Finance]
Riesgos
4
Oportunidades
4
Señales de alerta
3
Dirección
10
10 hallazgos más en el informe completo — gratis con cualquier cuenta.
Desbloquea el análisis completo de Edwards Lifesciences Corp
Crea una cuenta gratuita para acceder al informe completo generado con IA, con fuentes citadas en el texto.
- 4 riesgos, 4 oportunidades y 3 señales de alerta — cada uno con su fuente
- Más de 100 métricas financieras con gráficos y comparativas
- Resúmenes completos de noticias con enlaces a las fuentes
- Equipo directivo y remuneración
III · Empresas similares
También te puede interesar
Mismo sector · Salud — o salud financiera comparable
¿La añades a tu lista?